Search Keywords:

  Thursday, May 17, 2012

Untitled

North America

cnn.com
latimes.com
washingtonpost
cbc.ca
csmonitor.com
foxnews.com
msnbc.com
usatoday.com

Europe

belgiumpost.com
english.pravda.ru
bbcnews

Middle East

arabicnews.com
Jpost.com

Africa

allafrica.com
africaonline.com

South America

southamericadaily

Asia

japantimes.com
timesofindia.com
abc.com
 

Human Bionics and Xybernaut Development Corporation agree to combine novel Bio-adaptive User Interface (BUI™) technology with wearable computers and future Wearable Internet Appliances (WIA) to offer a truly hands-free interface.

[ 02/06/2001 ]
Human Bionics and Xybernaut Development Corporation agree to combine novel Bio-adaptive User Interface (BUI™) technology with wearable computers and future Wearable Internet Appliances (WIA) to offer a truly hands-free interface.
Human Bionics LLC (HB), and Xybernaut Development Corporation (XDC), a wholly owned subsidiary of Xybernaut Corporation (NASDAQ: XYBR) have signed a Memorandum of Understanding (MOU) as a continuing step in collaborative efforts. The firms intend to jointly develop new capabilities in hands-free operation of mobile computers, Wearable Internet Appliances (WIA), and interactive Video/PC games. Along with a Value Added Reseller (VAR) agreement between HB and Xybernaut Corporation, signed late last week, the initiative represents a decisive move to introduce advanced body and mind-activated controllers, in place of conventional hand-operated devices. The Bio-adaptive User Interface (BUI™ -- pronounced: "Boo-ee") is targeted at the mass-marketed communication and entertainment industries to drive down the cost of wearable computing systems.

Human Bionics' BUI product will effectively work in conjunction with natural language processing technology to replace the functionality of the mouse, joystick, and cumbersome game control devices. The BUI will be developed through an open source Software Development Kit (SDK) and sold under the name Cognitive Trigger Library™ (CTL™). HB's novel product will help software makers leverage their product and market positions through the enabling capabilities of our next generation technology.

The Human Bionics CTL is a software toolset for developers to include the use of a body-activated controller to operate their interactive programs. The embedded kernel works much the same as a Software Driver that is used to add a new device to a computer. The difference between HB's product and other controllers is that the BUI employs mental and/or physical activities from the head, arms, legs, or body rather than mouse movements and button presses.

Don DuRousseau, Human Bionics' founder and CEO said, "The proprietary BUI technology is the culmination of over 15 years of research and development projects from many different fields of science, and the time is ripe for turning yesterday's research into tomorrow's products."

The companies expect that BUI technology will be adopted for use in a variety of business applications, including industrial and commercial wearable computing, WIA devices, e-learning tools, health and security monitoring applications, and telemedicine products and services. The rollout timeframe for this exciting new product is expected to be 12-18 months. Human Bionics is now seeking industry partners and strategic relationships to speed product introduction.

About Human Bionics:

Human Bionics is a Limited Liability Company founded in February 2000. The firm is in business to develop and introduce unique capabilities in human-computer-interaction that will effect the way we all use computer systems. Their technology includes sophisticated adaptive-neural-network pattern recognition and classification methods used to identify specific changes in mental and physical activities and output control signals that work to operate the user interface. The company is currently discussing outside financing and related industry relationships. http://www.human-bionics.com/

About Xybernaut Development Corporation:

Xybernaut Development Corporation (XDC) is a wholly owned subsidiary of Xybernaut Corporation (NASDAQ: XYBR) aimed at successfully addressing critical corporate development activities. XDC is an organization focusing on the critical aspects needed to establish wearable computing as the next paradigm of computing and communications. "XDC will be that organization for Xybernaut" stated Dr. Steven A. Newman, Xybernaut's Vice Chairman who now assumes the position of President and CEO of XDC. "XDC will focus primarily on the many excellent worldwide business and/or partnership opportunities, as well as open new geographic markets outside of our existing North American, Asian and European operations." Newman added, "Additionally, it will identify and execute entry strategies and strategic partnerships for new Xybernaut vertical markets such as distance learning and telemedicine."

About Xybernaut Corporation:

Xybernaut Corporation is the leading provider of wearable computing hardware, software and services, bringing communications and full-function computing power in a hands-free design to people when and where they need it. The Mobile Assistant® IV (MA IV®), Xybernaut's patented wearable PC, runs all major PC operating systems, including Windows 98/2000/NT, Linux and SCO Unix. With the MA IV, customers can realize immediate savings in maintenance, repair, diagnosis, inspection, inventory control and data collection in a broad spectrum of industries, including manufacturing, distribution, utilities, government and transportation. Xybernaut also provides hyper linking, multimedia authoring tools, project management, asset management and speech software toolkits. Headquartered in Fairfax, Virginia, Xybernaut has offices and subsidiaries in Europe (Germany) and Asia (Japan). Visit Xybernaut's web site at www.xybernaut.com

Source:
XPRESS PRESS
 [ Back ]
 [ Top   ]

www.dialysisfinder.com

Publicity/Corporate News: Send Press Releases to mailto: News@MedicalNewsService.com
(c) 2000, 2001, 2002 MedicalNewsService.com
MedicalNewsService.com is a subsidiary of International Medical Publishing, Inc. All Rights Reserved.